Korean J Dermatol.
1984 Jun;22(3):255-262.
A Clinical Study of TravogenR and TravocortR / TravogenR Therapy in Superficial Fungal Diseases: Multicenter Trials
Abstract
- Isoconazole nitrate is one of the broad-spectrum antimycotic agents recently developed from imidazole derivatives. Authors performed ulticenter trials to evaluate the therapeutic effect of Travogen and Travocort in superficial fungal diseases. In the usual superficial fungal diseases, Travogen was applied 4 weeks. In the inflammatory and eczematoid superficial fungal diseases, Travocort was applied 2 weeks initially and then followed by 2 weeks application of Travogen. One hundred and ninty one patients with superficial fungal diseases were included in this study during g months from December, 1982 to August, 19$3 The obtained results were as follows; The overall cure rate of Travogen and Travocort in each superficial fungal diseases were gl 7g (tinea pedis), 98. L% (tinea cruris), 1ppg, (tinea corporis), 9g. 100% (tinea manus), 1ppg (tinea capitis) and 1pgg (candidiasis) respectively. Trichophyton rubrum(51. 3%), Trichophyton mentagrophytes(29.3g), Tricho -countinue-
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Clinical Study of Oral Ketoconazole Therapy in Superficial Fungal Diseases: Multicenter Trials
- A clinical and mycological study of superficial fungal diseases(vii)
- Superficial Fungal Infection in Patients with Atopic Dermatitis
- Epidemiology of Patients with Superficial Fungal Diseases and Their Family Members in Korea
- Epidemiologic Study of Superficial Fungal Infections in Outpatients of Dermatologic Clinic and Healthy Individuals
